MedPath
HSA Approval

ERYSON TABLETS 250 mg

SIN00578P

ERYSON TABLETS 250 mg

ERYSON TABLETS 250 mg

April 29, 1988

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

ENTERIC COATED TABLET

ORAL

Medical Information

J01FA01

erythromycin

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

ERYTHROMYCIN

250 mg

Erythromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.